Pharmaceutical

Announcing Olink® Explore HT – A New Era in Proteomics

A High-throughput Protein Biomarker Discovery Platform with Proven Specificity at Any Scale Olink Explore HT Olink® Explore HT is a…

12 months ago

Sharps Technology Appoints Industry Sales and Manufacturing Leader Ben Scheu as Senior Director of Sales

Key appointment with demonstrated experience in leading sales and marketing operations to oversee commercial initiatives as the Company launches its…

12 months ago

Recursion Announces Collaboration and $50 Million Investment from NVIDIA to Accelerate Groundbreaking Foundation Models in AI-Enabled Drug Discovery

Companies to collaborate on software for biotech and pharmaceutical companies to create improved patient treatments fasterSALT LAKE CITY, TORONTO and…

12 months ago

Apnimed to Participate in the William Blair Virtual Conference: Transitioning Biotech Breakthroughs to Commercial Success

CAMBRIDGE, Mass., July 12, 2023 (GLOBE NEWSWIRE) -- Apnimed, Inc., a clinical-stage pharmaceutical company focused on developing oral pharmacologic therapies…

12 months ago

Ultragenyx Appoints Howard Horn as Chief Financial Officer and Executive Vice President, Corporate Strategy

Howard Horn Ultragenyx announced Howard Horn has been appointed executive vice president and chief financial officer, effective October 16, 2023.NOVATO,…

12 months ago

LianBio Announces Clinical Supply Agreement with AstraZeneca in China to Evaluate BBP-398 in Combination with Osimertinib in Patients with Non-Small Cell Lung Cancer with EGFR Mutations

SHANGHAI, China and PRINCETON, N.J., July 12, 2023 (GLOBE NEWSWIRE) -- LianBio (Nasdaq: LIAN), a biotechnology company dedicated to bringing…

12 months ago

Aridis’ AR-301 Monoclonal Antibody is Among the First Biologics to Receive FDA’s Qualified Infectious Diseases Product (QIDP) Designation

QIDP designation for Biologics provides FDA Priority Review statusLOS GATOS, Calif., July 12, 2023 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc.…

12 months ago

Lumos Pharma to Participate in the Oppenheimer 2023 Montauk Life Sciences Summit

AUSTIN, Texas, July 12, 2023 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company advancing an oral therapeutic candidate for…

12 months ago

Ocular Therapeutix™ Announces Appointment of New Board Member

Dr. Adrienne Graves to join Board of DirectorsBEDFORD, Mass., July 12, 2023 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL), a…

12 months ago

Slynd® (drospirenone) is now covered by the Régie de l’assurance maladie du Québec

Slynd® Slynd® is now reimbursed for 100% of Quebec women to whom it is indicated.BLAINVILLE, Quebec, July 12, 2023 (GLOBE…

12 months ago